Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-515-7 | CAS number: 1236007-63-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Based on well documented journal article translated into English from the original Japanese
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 987
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other:
- Principles of method if other than guideline:
- A chronic toxicity test was conducted in which the substance was administered orally to male and female rats for 26 weeks. Since the doses were well above the usual acute toxicity test limit dose, and no mortality or marked clinical signs were observed, the study demonstrates the lack of acute toxicity.
- GLP compliance:
- not specified
- Remarks:
- Not stated but appears to be in compliance with GLP
- Test type:
- other:
- Limit test:
- no
Test material
Reference
- Name:
- Unnamed
- Type:
- Constituent
- Details on test material:
- Palatinose syrup (same as isomaltulose greens) is a byproduct of the process used to manufacture the reducing disaccharide palatinose. It is a monosaccharide/oligosaccharide composite principally composed of 1-O-2-D-glucosyl-D-fructose and palatinose. It contains 71.2% sugars, such as fructose, glucose, sucrose, palatinose, trehalulose, and isomaltose. It is equivalent to isomaltulose greens.
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Four-week-old Sprague-Dawley SPF rats (Crj: CD) were obtained from Charles River Laboratories Japan, Inc. and placed under quarantine for a preliminary period of 1 week for acclimation. The animals were kept in a controlled indoor barrier system equipped with 12-hour light cycle systems at 24+/- 1 degrees C and humidity 55 +/- 5%. Each rat was placed inside a metal cage with a wire-mesh floor and allowed free access to the commercial solid feed Rodent Diet CE-2 (CLEA Japan, Inc.) and tap water. At the beginning of the experiment the rats' body weights ranged from 97-118 g (females) and 114-131 g (males).
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- Doses were administered orally once a day for a period of 26 weeks (female: 183 days, male: 184 days) using gastric tubes. The palatinose syrup was stored at room temperature. The 4,500 mg/kg syrup was as received from the manufacturer and was dosed undiluted. Solutions for the 3,000 and 1,500 mg/kg groups were prepared by placing the appropriate amount of concentrated syrup in a graduated cylinder and adding distilled water until the w/v ratios of 64.4% and 32.2%, respectively, were achieved.
- Doses:
- Control, 1,500, 3,000, and 4,500 mg/kg, with a volume of 4,663 ml/kg body weight
- No. of animals per sex per dose:
- Four groups of 14 rats (male/female) were exposed to each dose level.
- Control animals:
- yes
- Details on study design:
- In addition to checking daily for mortality, general clinical symptoms, toxicity symptoms, and macroscopic feces and urine qualities for each rat were made once a week throughout the study. Body weight and individual food consumption were measured once a week for the first 13 weeks and then every two weeks thereafter. Additional measurements were made on regular schedules related to urinalysis, ophthalmological examination, hematological examination, blood biochemistry evaluation, and pathological examination.
- Statistics:
- Measured values are expressed as mean +/- SD. Student's t-test was used for statistically significant difference from the control group (P<0/05). In cases with unequal variance, the Aspin-Welch t-test was used to test for statistical significance.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 4 500 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No treatment related mortalities were observed during the entire 26 week exposure. Two female rats did die in weeks 13 and 14 of the study, but these were believed to be caused by perforation of the esophagus due to administration failure and were not treatment related.
- Clinical signs:
- No clinical signs of toxicity believed to have been caused by test material administration were observed.
- Body weight:
- A slight deceleration in weight gain was observed in the 4,500 mg/kg group in week 21 as compared to the control group. No other group showed any significant acceleration or deceleration in weight gain during the 26-week study period.
Applicant's summary and conclusion
- Interpretation of results:
- practically nontoxic
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The test material is practically non-toxic to rats when given high doses.
- Executive summary:
A toxicity test was conducted in which the substance was administered orally to male and female rats for 26 weeks. Doses (1,500, 3,000 and 4,500 mg/kg) were administered orally once a day. Two female rats did die in weeks 13 and 14 of the study, but these were believed to be caused by perforation of the esophagus due to administration failure and were not treatment related. No other mortalities were observed. Since the doses were well above the usual acute toxicity test limit dose, and no mortality or marked clinical signs were observed, the study demonstrates the lack of acute toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.